Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.730
+0.060 (3.59%)
At close: Mar 10, 2026, 4:00 PM EDT
1.730
0.00 (0.00%)
After-hours: Mar 10, 2026, 4:00 PM EDT
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $14.14 million as of March 10, 2026. Its market cap has decreased by -13.52% in one year.
Market Cap
14.14M
Enterprise Value
7.25M
1-Year Change
-13.52%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $14.14M, a decrease of -96.54%. That is a compound annual growth rate of -23.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 13.34M | 47.79% |
| Dec 31, 2025 | 9.03M | -72.02% |
| Dec 31, 2024 | 32.27M | 106.05% |
| Dec 29, 2023 | 15.66M | 15.90% |
| Dec 30, 2022 | 13.51M | -74.64% |
| Dec 31, 2021 | 53.27M | -38.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cocrystal Pharma | 14.20M |
| Quoin Pharmaceuticals | 14.19M |
| Curis | 14.10M |
| BioAtla | 14.04M |
| BioCardia | 13.58M |
| GT Biopharma | 13.16M |
| Kairos Pharma | 13.14M |
| Phio Pharmaceuticals | 13.02M |